Neovacs CEO Outlines Clinical Timeline For Lupus Drug
Executive Summary
Miguel Sieler, CEO of 25-year-old French vaccines company Neovacs, chats with Mike Ward, global director of content for Informa Pharma Intelligence, about the company's early lead in immuno-stimulation research.